HEATH GIBSON: Open Payments
NPI 1487178299 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 177 payments from 17 companies in 2025. Trend: 2023 $1,637 · 2024 $3,056 · 2025 $3,060
Food & beverage: $2,961Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $792 |
| Janssen Biotech, Inc. | 31 | $393 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 30 | $340 |
| Madrigal Pharmaceuticals | 11 | $291 |
| Phathom Pharmaceuticals, Inc. | 22 | $290 |
| QOL Medical, LLC | 9 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $222 |
| GENZYME CORPORATION | 9 | $141 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Gilead Sciences, Inc. | 3 | $72 |
Products named: RINVOQ, TREMFYA, XIFAXAN, REZDIFFRA, VOQUEZNA, DUPIXENT, Sucraid, ENTYVIO.
Industry payments across KY — which companies pay providers there.
